A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer
- 1 March 2015
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 27 (3) , 397-408
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1Oncogenesis, 2013
- MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor SignalingCell, 2012
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitorsNature, 2012
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionNature, 2012
- Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancerNature Genetics, 2012
- A public genome-scale lentiviral expression library of human ORFsNature Methods, 2011
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivationNature, 2010
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- P2Y2 Nucleotide Receptor-Mediated Responses in Brain CellsMolecular Neurobiology, 2010
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009